Alex Jadad
Alex Jadad is a Colombian-Canadian physician, researcher, educator, and innovator in the field of health and well-being. He is best known for his work in eHealth and palliative care, as well as his development of the Jadad scale, a tool for assessing the quality of randomized controlled trials.
Early life and education[edit | edit source]
Alex Jadad was born in Colombia. He completed his medical degree at the University of Antioquia, one of the most prestigious universities in Colombia. He then moved to Canada, where he completed a residency in anesthesia and a fellowship in pain management and palliative care at the University of Toronto.
Career[edit | edit source]
Jadad has held numerous academic and leadership positions throughout his career. He was the founding director of the Centre for Global eHealth Innovation, a joint initiative of the University Health Network and the University of Toronto. He has also served as a professor at the Dalla Lana School of Public Health at the University of Toronto.
Jadad's research has focused on improving the quality of life for people with chronic illness and terminal illness, and on the use of information technology to enhance health and well-being. He is perhaps best known for developing the Jadad scale, a widely used tool for assessing the quality of randomized controlled trials.
Awards and recognition[edit | edit source]
Jadad has received numerous awards and honors for his work, including the Order of Merit of Colombia, the highest civilian honor in his native country. He has also been recognized by the World Health Organization and the Canadian Institutes of Health Research for his contributions to global health and eHealth.
Personal life[edit | edit source]
Jadad is married and has two children. He is an advocate for work-life balance and mindfulness in medicine and in life.
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD